Ratio Therapeutics Radiopharmaceutical Manufacturing Facility
Radiopharmaceutical Therapies (RPTs) are specialized cancer treatments that use radioactive drugs to deliver radiation directly to tumor cells. By combining a radioactive isotope with a targeting molecule, these therapies destroy cancer cells while minimizing effects on healthy tissue. Ratio Therapeutics’ mission to advance the development of best-in-class RPTs for cancer treatment is driving the establishment…
Confidential Client Radiopharmaceutical R&D and Manufacturing Facility, Western US
Bringing Radiopharmaceutical Therapies (RPTs) from discovery to clinical scale requires a facility that can hold both functions at once: the controlled precision of early-stage research and the infrastructure demands of scalable production. Designing for that range, within a single operational environment, is the core challenge. SMRT is providing full architectural and engineering services for this…
RayzeBio Radiopharmaceutical Manufacturing Facility
Radiopharmaceutical therapeutics (RPTs) are an emerging and promising modality for next-generation cancer treatment. RPTs rely on therapeutic radioisotopes to deliver treatment with much higher precision than the current standard of care. For RayzeBio, a California-based radiopharmaceutical company, speed to market is critical for both product and company success. Due to the short half-life of radiopharmaceuticals,…